Pfizer Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Pfizer Ventures/Activity

Pfizer Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

News

Published its 2025 Year in Review brochure summarizing portfolio activity and investment strategy.

Pfizer Ventures 2025 Year in Review

Pfizer Ventures

Added recently

6 investments· JUL 2023 – JUN 2026Show all

Investment

Participated in Flare Therapeutics' $85M insider-led Series C, led by Third Rock Ventures and Nextech Invest.

Flare Therapeutics

Flare Therapeutics Pfizer Ventures

globenewswire.comJUN 30, 2026

JUN 30, 2026

Investment

Joined Crossbow Therapeutics' $77M Series B as a new investor, co-led by Taiho Ventures and Arkin Bio Capital.

Crossbow Therapeutics

Crossbow Therapeutics Pfizer Ventures

businesswire.comMAR 13, 2026

MAR 13, 2026

Investment

Co-led Enara Bio's $32.5M Series B (with M Ventures) to advance its Dark Antigen TCR-based immunotherapy pipeline.

Enara Bio

Enara Bio Pfizer Ventures

enarabio.comOCT 2024

OCT 2024

Investment

Added a $10M extension to Enlaza Therapeutics' $100M Series A, led by J.P. Morgan Private Capital's Life Sciences group.

Enlaza Therapeutics

Enlaza Therapeutics Pfizer Ventures

enlazatx.comAPR 30, 2024

APR 30, 2024

Investment

Led Curve Therapeutics' £40.5M Series A for its cyclic-peptide cancer drug discovery platform.

Curve Therapeutics

Curve Therapeutics Pfizer Ventures

curvetx.comFEB 27, 2024

FEB 27, 2024

Investment

Co-led Crossbow Therapeutics' $80M Series A launch alongside MPM BioImpact.

Crossbow Therapeutics

Crossbow Therapeutics Pfizer Ventures

vcaonline.comJUL 11, 2023

JUL 11, 2023